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We report the updated classification of primary immunodeficiencies (PIDs) compiled by the
Expert Committee of the International Union of Immunological Societies. In comparison to
the previous version, more than 30 new gene defects are reported in this updated version.
In addition, we have added a table of acquired defects that are phenocopies of PIDs. For
each disorder, the key clinical and laboratory features are provided.This classification is the
most up-to-date catalog of all known PIDs and acts as a current reference of the knowl-
edge of these conditions and is an important aid for the molecular diagnosis of patients
with these rare diseases.
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BACKGROUND
The International Union of Immunological Societies (IUIS)
Expert Committee on Primary Immunodeficiency met in New
York on 19th–21st April 2013 to update the classification of human
primary immunodeficiencies (PIDs). This report represents the
most current and complete catalog of known PIDs. It serves as a
reference for these conditions and provides a framework to help
in the diagnostic approach to patients suspected to have PID.
As in previous reports, we have classified the conditions into
major groups of PIDs and these are now represented in nine dif-
ferent tables. In each table, we list the condition, its genetic defect
if known, and the major immunological and in some conditions
the non-immunological abnormalities associated with the disease.
The classification this year differs slightly from the previous edition
in that Table 1 lists combined immunodeficiencies without non-
immunologic phenotypes, whereas Table 2 refers to combined
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Table 1 | Combined immunodeficiencies.
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
1. T−B+ severe combined immunodeficiency (SCID)
(a) γc deficiency Mutation of IL-2RG XL Markedly decreased Normal or
increased
Decreased Markedly decreased
NK cells
300400
Defect in γ chain of receptors
for IL-2, -4, -7, -9, -15, -21
(b) JAK3
deficiency
Mutation of JAK3 AR Markedly decreased Normal or
increased
Decreased Markedly decreased
NK cells
600173
Defect in Janus-activating
kinase 3
(c) IL7Rα
deficiency
Mutation of IL7RA AR Markedly decreased Normal or
increased
Decreased Normal NK cells 146661
Defect in IL-7 receptor α chain
(d) CD45
deficiencya
Mutation of PTPRC AR Markedly decreased Normal Decreased Normal γ/δT cells 151460
Defect in CD45
(e) CD3δ
deficiency
Mutation of CD3D AR Markedly decreased Normal Decreased Normal NK cells 186790
Defect in CD3δ chain of T cell
antigen receptor complex
No γ/δT cells
(f) CD3ε
deficiencya
Mutation of CD3E AR Markedly decreased Normal Decreased Normal NK cells 186830
Defect in CD3ε chain of T cell
antigen receptor complex
No γ/δT cells
(g) CD3ζ
deficiencya
Mutation of CD3Z AR Markedly decreased Normal Decreased Normal NK cells 186740
Defect in CD3ζ chain of T cell
antigen receptor complex
No γ/δT cells
(h) Coronin-1A
deficiencya
Mutation of CORO1A
defective thymic egress of T
cells and defective T cell
locomotion
AR Markedly decreased Normal Decreased Detectable thymus
EBV associated B cell
lymphoproliferation
605000
2. T−B− SCID
(i) DNA recombination defects
(a) RAG 1
deficiency
Mutation of RAG1 AR Markedly decreased Markedly
decreased
Decreased 601457
Defective VDJ recombination;
defect of recombinase
activating gene (RAG) 1
(a) RAG 2
deficiency
Mutation of RAG2 AR Markedly decreased Markedly
decreased
Decreased 601457
Defective VDJ recombination;
defect of recombinase
activating gene (RAG) 2
(b) DCLRE1C
(artemis)
deficiency
Mutation of ARTEMIS AR Markedly decreased Markedly
decreased
Decreased Radiation sensitivity 602450
Defective VDJ recombination;
defect in artemis DNA
recombinase repair protein
(c) DNA PKcs
deficiencya
Mutation of PRKDC -
Defective VDJ recombination;
defect in DNA PKcs
AR Markedly decreased Markedly
decreased
Decreased Radiation sensitivity,
microcephaly, and
developmental
defects
600899
Recombinase repair protein
(ii) Reticular
dysgenesis,
AK2 deficiency
Mutation of AK2 AR Markedly decreased Decreased or
normal
Decreased Granulocytopenia and
deafness
103020
Defective maturation of
lymphoid and myeloid cells
(stem cell defect)
Defect in mitochondrial
adenylate kinase 2
(Continued)
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Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
(iii) Adenosine
deaminase
(ADA)
deficiency
Mutation of ADA absent ADA
activity, elevated lymphotoxic
metabolites (dATP, S-adenosyl
homocysteine)
AR Absent from birth
(null mutations) or
progressive
decrease
Absent from
birth of
progressive
decrease
Progressive
decrease
Decreased NK cells,
often with
costochondral junction
flaring, neurological
features, hearing
impairment, lung and
liver manifestations;
partial ADA deficiency
may lead to delayed or
milder presentation
102700
Combined immunodeficiencies generally less profound than severe combined immunodeficiency
3. CD40 ligand
deficiency
Mutation of CD40LG defects
in CD40 ligand (CD40L; also
called TNFSF5 or CD154)
cause defective isotype
switching and impaired
dendritic cell signaling
XL Normal; may
progressively
decrease
sIgM+ and
sIgD+ B cells
present, other
surface isotype
positive B cells
absent
IgM increased
or normal,
other isotypes
decreased
Neutropenia,
thrombocytopenia;
hemolytic anemia,
biliary tract and liver
disease, opportunistic
infections
300386
4. CD40
deficiencya
Mutation of CD40 (also called
TNFRSF5) defects in CD40
cause defective isotype
switching and impaired
dendritic cell signaling
AR Normal IgM+ and IgD+
B cells present,
other isotypes
absent
IgM increased
or normal,
other isotypes
decreased
Neutropenia,
gastrointestinal and
liver/biliary tract
disease, opportunistic
infections
109535
5. Purine
nucleoside
phosphorylase
(PNP)
deficiency
Mutation of PNP, absent PNP,
and T cell and neurologic
defects from elevated toxic
metabolites, especially dGTP
AR Progressive
decrease
Normal Normal or
decreased
Autoimmune
hemolytic anemia,
neurological
impairment
164050
6. CD3γ
deficiencya
Mutation of CD3G defect in
CD3 γ – component of the T
cell antigen receptor complex
AR Normal, but reduced
TCR expression
Normal Normal 186740
7. CD8
deficiencya
Mutation of CD8A, defects of
CD8 α chain – important for
maturation and function of
CD8 T cells
AR Absent CD8, normal
CD4 cells
Normal Normal 186910
8. ZAP70
deficiency
Mutation in ZAP70
intracellular signaling kinase,
acts downstream of TCR
AR Decreased CD8,
normal CD4 cells
Normal Normal Autoimmunity in
some cases
269840
9. MHC class I
deficiency
Mutations in TAP1, TAP2, or
TAPBP (tapasin) genes giving
MHC class I deficiency
AR Decreased CD8,
normal CD4
Normal Normal Vasculitis; pyoderma
gangrenosum
604571
10. MHC class
II deficiency
Mutation in transcription
factors for MHC class II
proteins (CIITA, RFX5, RFXAP,
RFXANK genes)
AR Normal number,
decreased CD4 cells
Normal Normal or
decreased
Failure to thrive,
diarrhea, respiratory
tract infections,
liver/biliary tract
disease
209920
11. ITK
deficiencya
Mutations in ITK encoding
IL-2-inducible T cell kinase
required for TCR-mediated
activation
AR Progressive
decrease
Normal Normal or
decreased
EBV-associated B cell
lymphoproliferation,
lymphoma
613011
Normal or decreased
IgG
(Continued)
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Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
12. SH2D1A
deficiency
(XLP1)
Mutations in SH2D1A
encoding an adaptor protein
regulating intracellular signals
XL Normal or increased
activated T cells
Reduced
memory B cells
Partially
defective NK
cell and CTL
cytotoxic
activity
Clinical and
immunologic features
triggered by EBV
infection: HLH,
lymphoproliferation,
aplastic anemia,
lymphoma
308240
Hypogamma
globulinemia
Absent iNKT cells
13. Cartilage
hair hypoplasia
Mutations in RMRP (RNase
MRP RNA) involved in
processing of mitochondrial
RNA and cell cycle control
AR Varies from severely
decreased (SCID) to
normal; impaired
lymphocyte
proliferation
Normal Normal or
reduced.
antibodies
variably
decreased
Can present just as
combined
immunodeficiency
without other features
of short-limbed
dwarfism
250250
Also seeTable 2
14. MAGT1
deficiencya
Mutations in MAGT1,
impaired Mg++ flux leading to
impaired TCR signaling
XL Decreased CD4 cells
reduced numbers of
RTE, impaired T cell
proliferation in
response to CD3
Normal Normal EBV infection,
lymphoma; viral
infections, respiratory,
and GI infections
300715
15. DOCK8
deficiency
Mutations in
DOCK8 – regulator of
intracellular actin
reorganization
AR Decreased impaired
T lymphocyte
proliferation
Decreased, low
CD27+
memory B cells
Low IgM,
increased IgE
Low NK cells with
impaired function,
hypereosinophilia,
recurrent infections;
severe atopy,
extensive cutaneous
viral and bacterial
(staph.) infections,
susceptibility to
cancer
243700
16. RhoH
deficiencya
Mutations in RHOH – an
atypical Rho GTPase
transducing signals
downstream of various
membrane receptors
AR Normal Normal Normal HPV infection,
lymphoma, lung
granulomas,
molluscum
contagiosum
602037
Low naïve T cells
and RTE, restricted T
cell repertoire and
impaired T cells
proliferation in
response to CD3
stimulation
17. MST1
deficiency
Mutations in STK4 – a
serine/threonine kinase
AR Decreased/increased
proportion of
terminal
differentiated
effector memory
cells (TEMRA), low
naïve T cells,
restricted T cell
repertoire in the
TEMRA population,
and impaired T cells
proliferation
Decreased High Recurrent bacterial,
viral, and candidal
infections; intermittent
neutropenia;
EBV-driven
lymphoproliferation;
lymphoma; congenital
heart disease,
autoimmune
cytopenias; HPV
infection
614868
(Continued)
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Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
18. TCRα
deficiencya
Mutations in TRAC – essential
component of the T cell
receptor
AR Normal all CD3 T
cells expressed
TCRγδ (or may be
better to say: TCRαβ
T cell deficiency),
impaired T cells
proliferation
Normal Normal Recurrent viral,
bacterial, and fungal
infections, immune
dysregulation
autoimmunity, and
diarrhea
615387
19. LCK
deficiencya
Defects in LCK – a proximal
tyrosine kinase that interacts
with TCR
AR Normal total
numbers but CD4+
T cell lymphopenia,
low Treg numbers,
restricted T cell
repertoire, and
impaired TCR
signaling
Normal Normal IgG
and IgA and
increased IgM
Diarrhea, recurrent
infections, immune
dysregulation
autoimmunity
153390
20. MALT1
deficiencya
Mutations in MALT1 – a
caspase-like cysteine protease
that is essential for nuclear
factor kappa B activation
AR Normal impaired T
cells proliferation
Normal Normal Bacterial, fungal, and
viral infections
604860
Impaired
antibody
response
21. IL-21R
deficiencya
Defects in IL-21R – together
with common gamma chain
binds IL-21
AR Abnormal T cell
cytokine production;
abnormal T cell
proliferation to
specific stimuli
Normal Normal but
impaired
specific
responses
Susceptibility to
cryptosporidium and
pneumocystis and
cholangitis
605383
22. UNC119
deficiencya
Defects in UNC119 – an
activator of src tyrosine
kinases
AD Low T cells Mostly low Normal Recurrent bacterial,
fungal, and viral
infections
604011
CD4+T cell
lymphopenia,
impaired TCR
signaling
23. CARD11
deficiencya
Defects in CARD11 – acts as a
scaffold for NF-κB activity in
the adaptive immune
response
AR Normal
predominance of
naive T lymphocyte,
impaired T cells
proliferation
Normal
predominance
of transitional B
lymphocytes
Absent/low Pneumocystis jiroveci
pneumonia, bacterial
infections
615206
24. OX40
deficiencya
Defects in OX40 – a
co-stimulatory molecule
expressed on activated T cells
AR Normal T cell
numbers
Normal B cell
numbers
Normal Kaposi’s sarcoma;
impaired immunity to
HHV8
615593
Low levels of
antigen-specific
memory CD4+ cells
Lower
frequency of
memory B cells
25. IKBKB
deficiencya
Defects in IKBKB – encodes
IkB kinase 2 a component of
the NF-κB pathway
AR Normal total T cells;
absent regulatory
and gd T cells;
impaired TCR
activation
Normal B cell
numbers;
impaired BCR
activation
Decreased Recurrent bacterial,
viral, and fungal
infections; clinical
phenotype of SCID
615592
26. Activated
PI3K-δ
Mutation in PIK3CD, PI3K-δ AD
gain-of-function
Decreased total
numbers of T cells
Decreased total
peripheral B cell
and switched
memory B
cells; increased
transitional B
cells
Reduced IgG2
and impaired
antibody to
pneumococci
and
hemophilus
Respiratory infections,
bronchiectasis;
autoimmunity; chronic
EBV, and CMV
infection
602839
(Continued)
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Table 1 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
27. LRBA
deficiency
Mutations in LRBA
(lipopolysaccharide responsive
beige-like anchor protein)
AR Normal or decreased
CD4 numbers; T cell
dysregulation
Low or normal
numbers of B
cells
Reduced I IgG
and IgA in
most
Recurrent infections,
inflammatory bowel
disease,
autoimmunity; EBV
infections
606453
28. CD27
deficiencya
Mutations in CD27, encoding
TNF-R member superfamily
required for generation and
long-term maintenance of T
cell immunity
AR Normal No memory B
cells
Hypogamma
globulinemia
following EBV
infection
Clinical and
immunologic features
triggered by EBV
infection, HLH
615122
Aplastic anemia,
lymphoma
Hypogammaglobulinemia
Low iNKT cells
29. Omenn
syndrome
Hypomorphic mutations in
RAG1, RAG2, artemis, IL7RA,
RMRP, ADA, DNA ligase IV,
IL-2RG, AK2, or associated
with DiGeorge syndrome;
some cases have no defined
gene mutation
Present; restricted T
cell repertoire, and
impaired function
Normal or
decreased
Decreased,
except
increased IgE
Erythroderma,
eosinophilia,
adenopathies,
hepatosplenomegaly
603554
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; SCID, severe combined immune deficiencies; EBV, Epstein–Barr
virus; Ca++, calcium; MHC, major histocompatibility complex, RTE, recent thymic emigrants, HPV, human papillomavirus.
aTen or fewer unrelated cases reported in the literature.
Infants with SCID who have maternal T cells engraftment may have T cells that do not function normally; these cells may cause autoimmune cytopenias or graft
versus host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome (OS), or “leaky” SCID or a less profound
CID phenotype. Both OS and leaky SCID can be associated with higher numbers of T cells and reduced rather than absent activation responses when compared
with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, granulomas with T lymphopenia, autoimmunity,
and CD4+ T lymphopenia can be found with RAG gene defects. RAC2 deficiency is a disorder of leukocyte motility and is reported in Table 5; however, one patient
with RAC2 deficiency was found to have absent T cell receptor excision circles (TRECs) by newborn screening, but T cell numbers and mitogen responses were not
impaired. For additional syndromic conditions withT cell lymphopenia, such as DNA repair defects, cartilage hair hypoplasia, IKAROS deficiency, and NEMO syndrome,
see Tables 2 and 6; however, it should be noted that individuals with the most severe manifestations of these disorders could have clinical signs and symptoms of
SCID. Severe folate deficiency (such as with malabsorption due to defects in folate carrier or transporter genes SLC10A1 or PCFT) and some metabolic disorders,
such as methylmalonic aciduria, may present with reversible profound lymphopenia in addition to their characteristic presenting features.
immunodeficiencies with syndromic features, as increasing num-
bers of these are being identified. The title and classification of
Tables 3–8 present the same major PID groups as in the previous
report.
In this updated version, we have added a new category in
Table 9 in which “Phenocopies of PID” are listed. This has resulted
from our understanding and study of conditions that present as
inherited immunodeficiencies, but which are not due to germline
mutations and instead arise from acquired mechanisms. Examples
include somatic mutations in specific immune cell populations
that give rise to the phenotype of autoimmune lymphoprolifer-
ative syndrome (ALPS), and also autoantibodies against specific
cytokines or immunological factors, with depletion of these factors
leading to immunodeficiency. It is likely that increasing numbers
of PID phenocopies will be identified in the future, and this may
be the start of a much longer table.
As with all complex diseases, any classification cannot be strictly
adhered to. Certain conditions fall into more than one category
and so appear in more than one table. For example, CD40L ligand
deficiency is reported in both Tables 1 and 3 as it was initially
identified as a defect of B cell isotype switching but is now known
to be a defect of co-stimulatory T cell help and function. Similarly,
XLP1 due to defects in SH2D1A is listed in Table 1 – combined
immunodeficiencies, due to defects of T cell cytotoxicity, T cell
help, and B cell maturation, but also in Table 4 – diseases of
immune dysregulation, due to the susceptibility to hemophago-
cytosis. There is a growing appreciation that there can be wide
phenotypic viability within a specific genotype that is a prod-
uct of varied specific mutations between different patients as well
as other host and/or environmental factors. The complexities of
these conditions in terms of clinical and immunological presen-
tation and heterogeneity cannot be easily captured in the limited
space of a table format. For this reason, the furthest left column
contains the Online Mendelian Inheritance in Man (OMIM) ref-
erence for each condition to allow access to greater detail and
updated information.
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Table 2 | Combined immunodeficiencies with associated or syndromic features.
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
1. Congenital thrombocytopenia
(a) Wiskott–
Aldrich
syndrome
(WAS)
Mutations in WAS;
cytoskeletal, and immunologic
synapse defect affecting
hematopoietic stem cell
derivatives
XL Progressive
decrease, abnormal
lymphocyte
responses to
anti-CD3
Normal Decreased
IgM: antibody
to polysaccha-
rides
particularly
decreased;
often
increased IgA
and IgE
Thrombocytopenia
with small platelets;
eczema; lymphoma;
autoimmune disease;
IgA nephropathy;
bacterial and viral
infections. XL
thrombocytopenia is a
mild form of WAS, and
XL neutropenia is
caused by missense
mutations in the
GTPase binding
domain of WASP
301000
(b) WIP
deficiencya
Mutations in WIPF1;
cytoskeletal and immunologic
synapse defect affecting
hematopoietic stem cell
derivatives
AR Reduced, defective
lymphocyte
responses to
anti-CD3
Low Normal,
except for
increased IgE
Recurrent infections;
eczema;
thrombocytopenia.
WAS-like phenotype
614493
2. DNA repair defects (other than those inTable 1)
(a) Ataxia–
telangiectasia
Mutations in ATM ; disorder of
cell cycle checkpoint; and DNA
double-strand break repair
AR Progressive
decrease
Normal Often
decreased
IgA, IgE, and
IgG
subclasses;
increased IgM
monomers;
antibodies
variably
decreased
Ataxia; telangiectasia;
pulmonary infections;
lymphoreticular and
other malignancies;
increased alpha
fetoprotein and
increased
radiosensitivity;
chromosomal
instability
208900
(b) Ataxia–
telangiectasia-
like disease
(ATLD)a
Hypomorphic mutations in
MRE11; disorder of cell cycle
checkpoint and DNA
double-strand break repair
AR Progressive
decrease
Normal Antibodies
variably
decreased
Moderate ataxia;
pulmonary infections;
severely increased
radiosensitivity
604391
(c) Nijmegen
breakage
syndrome
Hypomorphic mutations in
NBS1 (Nibrin); disorder of cell
cycle checkpoint and DNA
double-strand break repair
AR Progressive
decrease
Variably
reduced
Often
decreased
IgA, IgE, and
IgG
subclasses;
increased
IgM;
antibodies
variably
decreased
Microcephaly; bird-like
face; lymphomas;
solid tumors;
increased
radiosensitivity;
chromosomal
instability
251260
(d) Bloom
syndrome
Mutations in BLM ; RecQ-like
helicase
AR Normal Normal Reduced Short stature; bird-like
face; sun-sensitive
erythema; marrow
failure; leukemia;
lymphoma;
chromosomal
instability
210900
(Continued)
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Table 2 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
(e) Immunodefi-
ciency with
centromeric
instability and
facial anomalies
(ICF)
Mutations in DNA
methyltransferase DNMT3B
(ICF1) resulting in defective
DNA methylation
AR Decreased or
normal; responses
to PHA may be
decreased
Decreased or
normal
Hypogamma
globulinemia;
variable
antibody
deficiency
Facial dysmorphic
features;
macroglossia;
bacterial/opportunistic
infections;
malabsorption;
cytopenias;
malignancies;
multiradial
configurations of
chromosomes 1, 9,
16; no DNA breaks
242860
(f) Immunodefi-
ciency with
centromeric
instability and
facial anomalies
(ICF)
Mutations in ZBTB24 (ICF2) AR Decreased or
normal; responses
to PHA may be
decreased
Decreased or
normal
Hypogamma
globulinemia;
variable
antibody
deficiency
Facial dysmorphic
features;
macroglossia;
bacterial/opportunistic
infections;
malabsorption;
cytopenias;
malignancies;
multiradial
configurations of
chromosomes 1, 9, 16
242860
(g) PMS2
deficiency
Mutations in PMS2, resulting
in class switch recombination
deficiency due to impaired
mismatch repair
AR Normal Switched and
non-switched B
cells are
reduced
Low IgG and
IgA, elevated
IgM, abnormal
antibody
responses
Recurrent infections;
café-au-lait spots;
lymphoma, colorectal
carcinoma, brain
tumor
600259
(h) RNF168
deficiencya
Mutations in RNF168,
resulting in defective DNA
double-strand break repair
AR Normal Normal Low IgG or
low IgA
Short stature; mild
motor control to ataxia
and normal
intelligence to learning
difficulties; mild facial
dysmorphism to
microcephaly;
increased
radiosensitivity
611943
(i) MCM4
deficiency
Mutations in MCM4
(minichromosome
maintenance complex
component 4) gene involved in
DNA replication and repair
AR Normal Normal Normal Viral infections (EBV,
HSV, VZV)
Adrenal failure
Short stature
609981
3. Thymic defects with additional congenital anomalies
(a) DiGeorge
anomaly
Contiguous gene defect in
90% affecting thymic
development; may also be due
to heterozygous mutation in
TBX1 (chromosome 22q11.2
deletion or TBX1
haploinsufficient syndrome)
De novo defect
(majority) or AD
Decreased or
normal; 5% have
<1500 CD3 T
cells/µL
Normal Normal or
decreased
Hypoparathyroidism,
conotruncal
malformation;
abnormal facies; large
deletion (3 Mb) in
22q11.2 (or rarely a
deletion in 10p)
188400
(Continued)
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Table 2 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
(b) CHARGE
syndrome
Variable defects of the thymus
and associated T cell
abnormalities often due to
deletions or mutations in
CHD7, SEMA3E, or as yet
unknown genes
De novo defect
(majority) or AD
Decreased or
normal; some have
<1500 CD3 T
cells/µL
Normal Normal or
decreased
Coloboma, heart
anomaly, choanal
atresia, retardation,
genital and ear
anomalies
214800
608892
4. Immune-osseous dysplasias
(a) Cartilage hair
hypoplasia
Mutations in RMRP (RNase
MRP RNA) involved in
processing of mitochondrial
RNA and cell cycle control
AR Varies from severely
decreased (SCID) to
normal; impaired
lymphocyte
proliferation
Normal Normal or
reduced.
Antibodies
variably
decreased
Short-limbed
dwarfism with
metaphyseal
dysostosis, sparse
hair, bone marrow
failure, autoimmunity,
susceptibility to
lymphoma and other
cancers, impaired
spermatogenesis,
neuronal dysplasia of
the intestine
250250
(b) Schimke
syndrome
Mutations in SMARCAL1
involved in chromatin
remodeling
AR Decreased Normal Normal Short stature,
spondiloepiphyseal
dysplasia, intrauterine
growth retardation,
nephropathy;
bacterial, viral, and
fungal infections; may
present as SCID; bone
marrow failure
242900
5. Hyper-IgE syndromes (HIES)
(a) AD-HIES
(Job’s
syndrome)
Dominant-negative
heterozygous mutations in
STAT3
AD
Often de novo
defect
Normal
Th-17 and T follicular
helper cells
decreased
Normal
Switched and
non-switched
memory B cells
are reduced;
BAFF level
increased
Elevated IgE;
specific
antibody
production
decreased
Distinctive facial
features (broad nasal
bridge), eczema,
osteoporosis, and
fractures, scoliosis,
delay of shedding
primary teeth,
hyperextensible joints,
bacterial infections
(skin and pulmonary
abscesses,
pneumatoceles) due
to Staphylococcus
aureus, candidiasis,
aneurysm formation
147060
(i) Tyk2
deficiencya
Mutation in TYK2 AR Normal, but multiple
cytokine signaling
defect
Normal (±) Elevated
IgE
Susceptibility to
intracellular bacteria
(Mycobacteria,
Salmonella), fungi,
and viruses
611521
(Continued)
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Table 2 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
(ii) DOCK8
deficiency
Mutations in
DOCK8 – regulator of
intracellular actin
reorganization
AR Decreased impaired
T lymphocyte
proliferation
Decreased, low
CD27+
memory B cells
Low IgM,
increased IgE
Low NK cells with
impaired function,
hypereosinophilia,
recurrent infections;
severe atopy,
extensive cutaneous
viral and bacterial
(staph.) infections,
susceptibility to
cancer
243700
6. Dyskeratosis congenital (DKC)
(a) XL-DKC Mutations in dyskerin (DKC1)
(Hoyeraal–Hreidarsson
syndrome)
XL Progressive
decrease
Progressive
decrease
Variable Intrauterine growth
retardation,
microcephaly, nail
dystrophy, recurrent
infections, digestive
tract involvement,
pancytopenia,
reduced number and
function of NK cells
305000
(b) AR-DKC due
to NHP2
deficiency
Mutation in NOLA2 (NHP2) AR Decreased Variable Variable Pancytopenia, sparse
scalp hair and
eyelashes, prominent
periorbital
telangiectasia, and
hypoplastic/dysplastic
nails
613987
(c) AR-DKC due
to NOP10
deficiency
Mutation in NOLA3 (NOP10
PCFT)
AR Decreased Variable Variable Pancytopenia, sparse
scalp hair and
eyelashes, prominent
periorbital
telangiectasia, and
hypoplastic/dysplastic
nails
224230
(d) AR-DKC due
to RTEL1
deficiency
Mutation in (RTEL1) AR Decreased Variable Variable Pancytopenia, sparse
scalp hair and
eyelashes, prominent
periorbital
telangiectasia, and
hypoplastic/dysplastic
nails
608833
(e) AD-DKC due
to TERC
deficiency
Mutation in TERC AD Variable Variable Variable Reticular
hyperpigmentation of
the skin, dystrophic
nails, osteoporosis
premalignant
leukokeratosis of the
mouth mucosa,
palmar hyperkeratosis,
anemia, pancytopenia
127550
(Continued)
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Table 2 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
(f) AD-DKC due
to TERT
deficiency
Mutation in TERT AD Variable Variable Variable Reticular
hyperpigmentation of
the skin, dystrophic
nails, osteoporosis
premalignant
leukokeratosis of the
mouth mucosa,
palmar hyperkeratosis,
anemia, pancytopenia
614742
(g) AD-DKC due
to TINF2
deficiency
Mutation in TINF2 AD Variable Variable Variable Reticular
hyperpigmentation of
the skin, dystrophic
nails, osteoporosis
premalignant
leukokeratosis of the
mouth mucosa,
palmar hyperkeratosis,
anemia, pancytopenia
613990
7. Defects of vitamin B12 and folate metabolism
(a) TCN2
deficiency
Mutation in TCN2; encodes
transcobalamin, a transporter
of cobalamin into blood cells
AR Normal Variable Decreased Megaloblastic anemia,
pancytopenia,
untreated for
prolonged periods
results in mental
retardation
275350
(b) SLC46A1
deficiency
Mutation in SLC46A1; a
proton coupled folate
transporter
AR Variable numbers
and activation profile
Variable Decreased Megaloblastic anemia,
failure to thrive
untreated for
prolonged periods
results in mental
retardation
229050
(c) MTHFD1a
deficiency
Mutations in MTHFD1;
essential for processing of
single-carbon folate
derivatives
AR Low Low Decreased Megaloblastic anemia,
failure to thrive
neutropenia, seizures,
mental retardation
8. Comel–
Netherton
syndrome
Mutations in SPINK5 resulting
in lack of the serine protease
inhibitor LEKTI, expressed in
epithelial cells
AR Normal Switched and
non-switched B
cells are
reduced
Elevated IgE
and IgA
Congenital ichthyosis,
bamboo hair, atopic
diathesis, increased
bacterial infections,
failure to thrive
256500
Antibody
variably
decreased
9. Winged helix
deficiency
(Nude)a
Defects in forkhead box N1
transcription factor encoded
by FOXN1
AR Markedly decreased Normal Decreased Alopecia, abnormal
thymic epithelium,
impaired T cell
maturation
600838
10. ORAI-I
deficiencya
Mutation in ORAI1, a Ca++
release-activated channel
(CRAC) modulatory
component
AR Normal number, but
defective
TCR-mediated
activation
Normal Normal Autoimmunity,
anhydrotic ectodermic
dysplasia,
non-progressive
myopathy defective
TCR-mediated
activation
610277
(Continued)
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Table 2 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Serum Ig Associated
features
OMIM
number
11. STIM1
deficiencya
Mutations in STIM1, a stromal
interaction molecule 1
AR Normal number, but
defective
TCR-mediated
activation
Normal Normal Autoimmunity,
anhydrotic ectodermal
dysplasia,
non-progressive
myopathy defective
TCR-mediated
activation
605921
12. STAT5b
deficiencya
Mutations in STAT5B, signal
transducer, and transcription
factor, essential for normal
signaling from IL-2 and 15, key
growth factors for T and NK
cells
AR Modestly decreased Normal Normal Growth-hormone
insensitive dwarfism
245590
Dysmorphic features
Eczema
Lymphocytic
interstitial
pneumonitis,
autoimmunity
13. Hepatic
veno-occlusive
disease with
immunodefi-
ciency
(VODI)
Mutations in SP110 AR Normal (decreased
memory T cells)
Normal
(decreased
memory B
cells)
Decreased
IgG, IgA, IgM,
absent
germinal
centers,
absent tissue
plasma cells
Hepatic
veno-occlusive
disease;
Pneumocystis jiroveci
pneumonia;
susceptibility to CMV,
Candida;
thrombocytopenia;
hepatosplenomegaly
235550
14. IKAROS
deficiencya
Mutation in IKAROS AD de novo Normal, but
impaired lymphocyte
proliferation
Absent Presumably
decreased
Anemia, neutropenia,
thrombocytopenia
Not
assigned
15. FILS
syndromea
Mutation in POLE1; defective
DNA replication
AR Low naïve T cells;
decreased T cell
proliferation
Low memory B
cells
Decreased
IgM and IgG;
lack of
antibodies to
polysaccha-
ride
antigens
Mild facial
dysmorphism (malar
hypoplasia, high
forehead), livedo,
short stature;
recurrent upper and
lower respiratory tract
infections, recurrent
pulmonary infections,
and recurrent
meningitis
615139
16. Immunode-
ficiency with
multiple
intestinal
atresias
Mutation in TTC7A
[tetratricopeptide repeat (TPR)
domain 7A] protein of
unknown function
AR Variable, but
sometimes absent
Normal Decreased Multiple intestinal
atresias, often with
intrauterine
polyhydramnios and
early demise; some
with SCID phenotype
243150
SCID, severe combined immune deficiencies; XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; MSMD, Mendelian
susceptibility of mycobacterial disease.
aTen or fewer unrelated cases reported in the literature.
T and B cell number and function in these disorders exhibit a wide range of abnormality; the most severely affected cases meet diagnostic criteria for SCID or leaky
SCID and require immune system restoring therapy such as allogeneic hematopoietic cell transplantation. While not all DOCK8-deficient patients have elevated serum
IgE, most have recurrent viral infections and malignancies as a result of combined immunodeficiency. AR-HIES due toTyk2 deficiency is also listed inTable 6, because
of its association with atypical mycobacterial disease resulting in MSMD. Riddle syndrome is caused by mutations in a gene involved in DNA double-strand break
repair and is associated with hypogammaglobulinemia. Autosomal dominant and autosomal recessive forms of dyskeratosis congenita are included in this table.
IKAROS-deficiency represents a single prematurely born infant who died at the age of 87 days and who had absent B and NK cells and non-functional T cells.
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Table 3 | Predominantly antibody deficiencies.
Disease Genetic defect/
presumed pathogenesis
Inheritance Serum Ig Associated features OMIM
number
1. Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells
(a) BTK deficiency Mutations in BTK, a cytoplasmic
tyrosine kinase activated by
crosslinking of the BCR
XL All isotypes decreased in
majority of patients; some
patients have detectable
immunoglobulins
Severe bacterial infections;
normal numbers of pro-B cells
300300
(b) µ Heavy chain
deficiency
Mutations in µ heavy chain;
essential component of the
pre-BCR
AR All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
147020
(c) λ5 Deficiencya Mutations in l5; part of the
surrogate light chain in the
pre-BCR
AR All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
146770
(d) Igα deficiencya Mutations in Iga (CD79a); part of
the pre-BCR and BCR
AR All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
112205
(e) Igβ deficiencya Mutations in Igb (CD79β); part of
the pre-BCR and BCR
AR All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
147245
(f) BLNK deficiencya Mutations in BLNK ; a scaffold
protein that binds to BTK
AR All isotypes decreased Severe bacterial infections;
normal numbers of pro-B cells
604615
(g) PI3 kinase
deficiencya
Mutations in PIK3R1; a kinase
involved in signal transduction in
multiple cell types
AR All isotypes decreased Severe bacterial infections;
decreased or absent pro-B cells
171833
(h) E47 transcription
factor deficiencya
Mutations in TCF3; a
transcription factor required for
control of B cell development
AD All isotypes decreased Recurrent bacterial infections 147141
(i) Myelodysplasia
with hypogamma-
globulinemia
May have monosomy 7, trisomy
8, or dyskeratosis congenita
Variable One or more isotypes may
be decreased
Infections; decreased number of
pro-B cells
Not
assigned
(j) Thymoma with
immunodeficiency
Unknown None One or more isotypes may
be decreased
Bacterial and opportunistic
infections; autoimmunity;
decreased number of pro-B cells
Not
assigned
2. Severe reduction in at least two serum immunoglobulin isotypes with normal or low number of B cells
(a) Common variable
immunodeficiency
disorders
Unknown Variable Low IgG and IgA and/or
IgM
Clinical phenotypes vary: most
have recurrent infections, some
have polyclonal
lymphoproliferation,
autoimmune cytopenias, and/or
granulomatous disease
Not
assigned
(b) ICOS deficiencya Mutations in ICOS; a
co-stimulatory molecule
expressed on T cells
AR Low IgG and IgA and/or
IgM
Recurrent infections;
autoimmunity, gastroenteritis,
granuloma in some
604558
(c) CD19 deficiencya Mutations in CD19;
transmembrane protein that
amplifies signal through BCR
AR Low IgG and IgA and/or
IgM
Recurrent infections; may have
glomerulonephritis
107265
(d) CD81 deficiencya Mutations in CD81;
transmembrane protein that
amplifies signal through BCR
AR Low IgG, low or normal
IgA and IgM
Recurrent infections; may have
glomerulonephritis
186845
(Continued)
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Table 3 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Serum Ig Associated features OMIM
number
(e) CD20 deficiencya Mutations in CD20; a B cell
surface receptor involved in B
cell development and plasma cell
differentiation
AR Low IgG, normal or
elevated IgM and IgA
Recurrent infections 112210
(f) CD21 deficiencya Mutations in CD21; also known
as complement receptor 2 and
forms part of the CD19 complex
AR Low IgG; impaired
anti-pneumococcal
response
Recurrent infections 614699
(g) TACI deficiency Mutations in TNFRSF13B (TACI);
a TNF receptor family member
found on B cells and is a
receptor for BAFF and APRIL
AD or AR or
complex
Low IgG and IgA and/or
IgM
Variable clinical expression 604907
(h) LRBA deficiency Mutations in LRBA
(lipopolysaccharide responsive
beige-like anchor protein)
AR Reduced I IgG and IgA in
most
Recurrent infections,
inflammatory bowel disease,
autoimmunity; EBV infections
606453
(i) BAFF receptor
deficiencya
Mutations in TNFRSF13C
(BAFF-R); a TNF receptor family
member found on B cells and is
a receptor for BAFF
AR Low IgG and IgM Variable clinical expression 606269
(j) TWEAKa Mutations in TWEAK AD Low IgM and IgA; lack of
anti-pneumococcal
antibody
Pneumonia, bacterial infections,
warts; thrombocytopenia.
neutropenia
602695
(k) NFKB2
deficiencya
Mutations in NFKB2; an
essential component of the
non-canonical NF-κB pathway
AD Low IgG and IgA and IgM Recurrent infections 615577
(l) Warts, hypogam-
maglobulinemia,
infections,
myelokathexis
(WHIM) syndrome
Gain-of-function mutations of
CXCR4, the receptor for CXCL12
AD Panhypogammaglobulinemia,
decreased B cells
Warts/human papilloma virus
(HPV) infection
Neutropenia
Reduced B cell number
Hypogammaglobulinemia
193670
3. Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells
(a) CD40L deficiency Mutations in CD40LG (also
called TNFSF5 or CD154)
XL IgG and IgA decreased;
IgM may be normal or
increased; B cell numbers
may be normal or
increased
Bacterial and opportunistic
infections, neutropenia,
autoimmune disease
300386
(b) CD40 deficiencya Mutations in CD40 (also called
TNFRSF5 )
AR Low IgG and IgA; normal
or raised IgM
Bacterial and opportunistic
infections, neutropenia,
autoimmune disease
109535
(c) AID deficiency Mutations in AICDA gene AR IgG and IgA decreased;
IgM increased
Bacterial infections, enlarged
lymph nodes, and germinal
centers
605257
(d) UNG deficiency Mutations in UNG AR IgG and IgA decreased;
IgM increased
Enlarged lymph nodes and
germinal centers
191525
4. Isotype or light chain deficiencies with generally normal numbers of B cells
(a) Ig heavy chain
mutations and
deletions
Mutation or chromosomal
deletion at 14q32
AR One or more IgG and/or
IgA subclasses as well as
IgE may be absent
May be asymptomatic Not
assigned
(Continued)
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Table 3 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Serum Ig Associated features OMIM
number
(b) κ Chain
deficiencya
Mutations in Kappa constant
gene
AR All immunoglobulins have
lambda light chain
Asymptomatic 147200
(c) Isolated IgG
subclass deficiency
Unknown Variable Reduction in one or more
IgG subclass
Usually asymptomatic; a
minority may have poor antibody
response to specific antigens
and recurrent viral/bacterial
infections
Not
assigned
(d) IgA with IgG
subclass deficiency
Unknown Variable Reduced IgA with
decrease in one or more
IgG subclass
Recurrent bacterial infections Not
assigned
(e) PRKC δ
deficiencya
Mutation in PRKCD; encoding a
member of the protein kinase C
family critical for regulation of
cell survival, proliferation, and
apoptosis
AR Low IgG levels; IgA and
IgM above the normal
range
Recurrent infections; EBV
chronic infection
Lymphoproliferation SLE-like
autoimmunity (nephrotic and
antiphospholipid syndromes)
615559
(f) Activated PI3K-δ Mutation in PIK3CD, PI3K-δ AD gain-of-
function
Reduced IgG2 and
impaired antibody to
pneumococci and
hemophilus
Respiratory infections,
bronchiectasis; autoimmunity;
chronic EBV, CMV infection
602839
(g) Selective IgA
deficiency
Unknown Variable IgA decreased/absent Usually asymptomatic; may have
recurrent infections with poor
antibody responses to
carbohydrate antigens; may have
allergies or autoimmune disease.
A very few cases progress to
CVID, others coexist with CVID
in the family
137100
5. Specific antibody
deficiency with
normal Ig concen-
trations and normal
numbers of B cells
Unknown Variable Normal Reduced ability to produce
antibodies to specific antigens
Not
assigned
6. Transient
hypogammaglobu-
linemia of infancy
with normal
numbers of B cells
Unknown Variable IgG and IgA decreased Normal ability to produce
antibodies to vaccine antigens,
usually not associated with
significant infections
Not
assigned
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; BTK, Bruton tyrosine kinase; BLNK, B cell linker protein; AID,
activation-induced cytidine deaminase; UNG, uracil-DNA glycosylase; ICOS, inducible costimulator; Ig(κ), immunoglobulin or κ light chain type.
aTen or fewer unrelated cases reported in the literature.
Several autosomal recessive disorders that might previously have been called CVID have been added to Table 3. CD81 is normally co-expressed with CD19 on the
surface of B cells. As for CD19 mutations, mutations in CD81 result in normal numbers of peripheral blood B cells, low serum IgG, and an increased incidence of
glomerulonephritis. Single patient with a homozygous mutation in CD20 and CD21 has been reported.
Common variable immunodeficiency disorders (CVID) include several clinical and laboratory phenotypes that may be caused by distinct genetic and/or environ-
mental factors. Some patients with CVID and no known genetic defect have markedly reduced numbers of B cells as well as hypogammaglobulinemia. Alterations
in TNFRSF13B (TACI) and TNFRSF13C (BAFF-R) sequences may represent disease-modifying mutations rather than disease causing mutations. CD40L and CD40
deficiency are included in Table 1 as well as this table. A small minority of patients with XLP (Table 4), WHIM syndrome (Table 6), ICF (Table 2), VOD1 (Table 2),
thymoma with immunodeficiency (Good syndrome), or myelodysplasia are first seen by an immunologist because of recurrent infections, hypogammaglobulinemia,
and normal or reduced numbers of B cells. Patients with GATA2 mutations (Table 5) may have markedly reduced numbers of B cells, as well as decreased monocytes
and NK cells, and a predisposition to myelodysplasia but they do not usually have an antibody deficiency.
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Table 4 | Diseases of immune dysregulation.
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Functional
defect
Associated
features
OMIM
number
1. Familial hemophagocytic lymphohistiocytosis (FHL) syndromes
1.1 FHL syndromes without hypopigmentation
(a) Perforin
deficiency
(FHL2)
Mutations in PRF1; perforin
is a major cytolytic protein
AR Increased
activated T
cells
Normal Decreased to
absent NK and CTL
activities
(cytotoxicity)
Fever, hepatosplenomegaly
(HSMG), hemophagocytic
lymphohistiocytosis (HLH),
cytopenias
603553
(b) UNC13D/
Munc13-4
deficiency
(FHL3)
Mutations in UNC13D a;
required to prime vesicles
for fusion
AR Increased
activated T
cells
Normal Decreased to
absent NK and CTL
activities
(cytotoxicity and/or
degranulation)
Fever, HSMG, HLH,
cytopenias
608898
(c) Syntaxin 11
deficiency
(FHL4)
Mutations in STX11,
required for secretory
vesicle fusion with the cell
membrane
AR Increased
activated T
cells
Normal Decreased NK
activity
(cytotoxicity and/or
degranulation)
Fever, HSMG, HLH,
cytopenias
603552
(d) STXBP2/
Munc18-2
deficiency
(FHL5)
Mutations in STXBP2,
required for secretory
vesicle fusion with the cell
membrane
AR Increased
activated T
cells
Normal Decreased NK and
CTL activities
(cytotoxicity and/or
degranulation)
Fever, HSMG, HLH,
cytopenias
613101
1.2. FHL syndromes with hypopigmentation
(a) Chediak–
Higashi
syndrome
Mutations in LYST
Impaired lysosomal
trafficking
AR Increased
activated T
cells
Normal Decreased NK and
CTL activities
(cytotoxicity and/or
degranulation)
Partial albinism 214500
Recurrent infections, fever
HSMG, HLH
Giant lysosomes,
neutropenia, cytopenias
Bleeding tendency
Progressive neurological
dysfunction
(b) Griscelli
syndrome,
type 2
Mutations in RAB27A
encoding a GTPase that
promotes docking of
secretory vesicles to the
cell membrane
AR Normal Normal Decreased NK and
CTL activities
(cytotoxicity and/or
degranulation)
Partial albinism, fever,
HSMG, HLH, cytopenias
607624
(c) Hermansky–
Pudlak
syndrome,
type 2
Mutations in AP3B1 gene,
encoding for the b subunit
of the AP-3 complex
AR Normal Normal Decreased NK and
CTL activities
(cytotoxicity and/or
degranulation)
Partial albinism 608233
Recurrent infections
Pulmonary fibrosis
Increased bleeding
Neutropenia
HLH
2. Lymphoproliferative syndromes
(a) SH2D1A
deficiency
(XLP1)
Mutations in SH2D1A
encoding an adaptor
protein regulating
intracellular signaling
XL Normal or
increased
activated T
cells
Reduced
memory B
cells
Partially defective
NK cell and CTL
cytotoxic activity
Clinical and immunological
features triggered by EBV
infection: HLH
308240
Lymphoproliferation, aplastic
anemia, lymphoma
Hypogammaglobulinemia
Absent iNKT cells
(Continued)
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Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Functional
defect
Associated
features
OMIM
number
(b) XIAP
deficiency
(XLP2)
Mutations in XIAP/BIRC4
encoding an inhibitor of
apoptosis
XL Normal or
increased
activated T
cells;
low/normal
iNK T cells
Normal or
reduced
memory B
cells
Increased T cells
susceptibility to
apoptosis to CD95
and enhanced
activation-induced
cell death (AICD)
EBV infection, splenomegaly,
lymphoproliferation
HLH, colitis, IBD, hepatitis
Low iNKT cells
300635
(c) ITK
deficiencya
Mutations in ITK encoding
IL-2 inducible T cell kinase
required for TCR-mediated
activation
AR Progressive
decrease
Normal Decreased T cell
activations
EBV-associated B cell
lymphoproliferation,
lymphoma
613011
Normal or decreased IgG
(d) CD27
deficiencya
Mutations in CD27,
encoding TNF-R member
superfamily required for
generation and long-term
maintenance of T cell
immunity
AR Normal No memory
B cells
Low T and NK cells
functions
Clinical and immunological
features triggered by EBV
infection: HLH
615122
Aplastic anemia, lymphoma,
hypogammaglobulinemia
Low iNKT cells
3. Genetic defects of regulatory T cells
(a) IPEX,
immune
dysregulation,
polyen-
docrinopathy,
enteropathy
X-linked
Mutations in FOXP3,
encoding a T cell
transcription factor
XL Normal Normal Lack of (and/or
impaired function
of) CD4+ CD25+
FOXP3+ regulatory
T cells (Tregs)
Autoimmune enteropathy 304790
Early-onset diabetes
Thyroiditis, hemolytic
anemia, thrombocytopenia,
eczema
Elevated IgE, IgA
(b) CD25
deficiencya
Mutations in IL-2RA,
encoding IL-2Rα chain
AR Normal to
decreased
Normal No CD4+ C25+
cells with impaired
function of Tregs
cells
Lymphoproliferation,
autoimmunity. Impaired T
cell proliferation
606367
(c) STAT5b
deficiencya
Mutations in STAT5B,
signal transducer, and
transcription factor,
essential for normal
signaling from IL-2 and 15,
key growth factors for T
and NK cells
AR Modestly
decreased
Normal Impaired
development and
function of γδT
cells, Tregs, and NK
cells
Low T cell
proliferation
Growth-hormone insensitive
dwarfism
245590
Dysmorphic features
Eczema
Lymphocytic interstitial
pneumonitis, autoimmunity
4. Autoimmunity without lymphoproliferation
(a) APECED
(APS-1),
autoimmune
polyen-
docrinopathy
with candidiasis
and ectodermal
dystrophy
Mutations in AIRE,
encoding a transcription
regulator needed to
establish thymic
self-tolerance
AR Normal Normal AIRE-1 serves as
checkpoint in the
thymus for
negative selection
of autoreactive T
cells and for
generation of Tregs
Autoimmunity:
hypoparathyroidism
hypothyroidism, adrenal
insufficiency, diabetes,
gonadal dysfunction, and
other endocrine
abnormalities
240300
Chronic mucocutaneous
candidiasis
Dental enamel hypoplasia
Alopecia areata
Enteropathy, pernicious
anemia
(Continued)
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Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Functional
defect
Associated
features
OMIM
number
(b) ITCH
deficiencya
Mutations in ITCH, an E3
ubiquitin ligase catalyzes
the transfer of ubiquitin to
a signaling protein in the
cell including
phospholipase Cγ1 (PLCγ1)
AR Not assessed Not
assessed
Itch deficiency may
cause immune
dysregulation by
affecting both
anergy induction in
autoreactive
effector T cells and
generation of Tregs
Early-onset chronic lung
disease (interstitial
pneumonitis)
613385
Autoimmune disorder
(thyroiditis, type I diabetes,
chronic diarrhea/enteropathy,
and hepatitis)
Failure to thrive,
developmental delay,
dysmorphic facial features
5. Autoimmune lymphoproliferative syndrome (ALPS)
(a) ALPS–FAS Germinal mutations in
TNFRSF6, encoding
CD95/Fas cell surface
apoptosis receptorb
AD Increased
CD4−CD8−
TCRα/β double
negative (DN)
T cells
Normal, low
memory B
cells
Apoptosis defect
FAS mediated
Splenomegaly,
adenopathies, autoimmune
cytopenias
601859
ARc Increased lymphoma risk
IgG and A normal or
increased
Elevated FasL and IL-10,
vitamin B12
(b) ALPS–
FASLG
Mutations in TNFSF6, Fas
ligand for CD95 apoptosis
AR Increased DN
T cells
Normal Apoptosis defect
FAS mediated
Splenomegaly,
adenopathies, autoimmune
cytopenias, SLE
134638
Soluble FasL is not elevated
(c) ALPS–
caspase 10a
Mutations in CASP10,
intracellular apoptosis
pathway
AD Increased DN
T cells
Normal Defective
lymphocyte
apoptosis
Adenopathies,
splenomegaly, autoimmunity
603909
(d) ALPS–
caspase 8a
Mutations in CASP8,
intracellular apoptosis, and
activation pathways
AR Slightly
increased DN
T cells
Normal Defective
lymphocyte
apoptosis and
activation
Adenopathies,
splenomegaly, bacterial and
viral infections,
hypogammaglobulinemia
607271
(e) FADD
deficiencya
Mutations in FADD
encoding an adaptor
molecule interacting with
FAS, and promoting
apoptosis
AR Increased DN
T cells
Normal Defective
lymphocyte
apoptosis
Functional hyposplenism,
bacterial and viral infections
613759
Recurrent episodes of
encephalopathy and liver
dysfunction
(f) CARD11
gain-of-function
(GOF)
mutationsa
GOF mutations in CARD11,
encoding a protein required
for antigen
receptor–induced NF-κB
activation in B and T
lymphocytes
AD Normal Increased
M+D+CD19+
CD20+ B
cells
Constitutive
activation of NF-κB
in B & T
Lymphoproliferation 606445
Bacterial and viral infections
EBV chronic infection
Autoimmune cytopenia
Hypogammaglobulinemia
(g) PRKCδ
deficiencya
Mutations in PRKCD,
encoding a member of the
protein kinase C family
critical for regulation of cell
survival, proliferation, and
apoptosis
AR Normal Low
memory B
cells and
elevation of
CD5 B cells
Apoptotic defect in
B cells
Recurrent infections; EBV
chronic infection
615559
Lymphoproliferation
SLE-like autoimmunity
(nephrotic and
antiphospholipid syndromes)
HypoIgG
(Continued)
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Table 4 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Functional
defect
Associated
features
OMIM
number
6. Immune dysregulation with colitis
(a) IL-10
deficiencya
Mutations in IL-10,
encoding IL-10
AR Normal Normal No functional IL-10
secretion
Inflammatory bowel disease
(IBD) folliculitis
Not
assigned
Recurrent respiratory
diseases
Arthritis
(b) IL-10Rα
deficiency
Mutations in IL-10RA,
encoding IL-10R1
AR Normal Normal Leukocytes, no
response to IL-10
IBD, folliculitis 613148
Recurrent respiratory
diseases
Arthritis, lymphoma
(c) IL-10Rβ
deficiency
Mutations in IL-10RB,
encoding IL-10R2
AR Normal Normal Leukocytes, no
response to IL-10,
IL-22, IL-26, IL-28A,
IL-28B, and IL-29
IBD, folliculitis 612567
Recurrent respiratory
diseases
Arthritis, lymphoma
7. Type 1 interferonopathies
(a) TREX1
deficiency,
Aicardi–
Goutieres
syndrome 1
(AGS1)
Mutations in TREX1,
encoding nuclease involves
in clearing cellular nucleic
debris
AR Not assessed Not
assessed
Intracellular
accumulation of
abnormal
single-stranded
(ss) DNA species
leading to
increased CSF
alpha-IFN
production
Progressive encephalopathy
intracranial calcifications
606609
ADe Cerebral atrophy,
leukodystrophy
HSMG, thrombocytopenia
Elevated hepatic
transaminases
Chronic cerebrospinal fluid
(CSF) lymphocytosis
(b) RNASEH2B
deficiency,
AGS2
Mutations in RNASEH2B,
encoding nuclease subunit
involves in clearing cellular
nucleic debris
AR Not assessed Not
assessed
Intracellular
accumulation of
abnormal ss-DNA
species leading to
increased CSF
alpha-IFN
production
Progressive encephalopathy
intracranial calcifications
610326
Cerebral atrophy,
leukodystrophy
HSMG, thrombocytopenia
Elevated hepatic
transaminases
Chronic CSF lymphocytosis
(c) RNASEH2C
deficiency,
AGS3
Mutations in RNASEH2C,
encoding nuclease subunit
involves in clearing cellular
nucleic debris
AR Not assessed Not
assessed
Intracellular
accumulation of
abnormal ss-DNA
species leading to
increased CSF
alpha-IFN
production
Progressive encephalopathy
intracranial calcifications
610330
Cerebral atrophy,
leukodystrophy
HSMG, thrombocytopenia
Elevated hepatic
transaminases
Chronic CSF lymphocytosis
(d) RNASEH2A
deficiency,
AGS4a
Mutations in RNASEH2A,
encoding nuclease subunit
involves in clearing cellular
nucleic debris
AR Not assessed Not
assessed
Intracellular
accumulation of
abnormal ss-DNA
species leading to
increased CSF
alpha-IFN
production
Progressive encephalopathy
intracranial calcifications
606034
Cerebral atrophy,
leukodystrophy
HSMG, thrombocytopenia
Elevated hepatic
transaminases
Chronic CSF lymphocytosis
(Continued)
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Table 4 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Circulating
T cells
Circulating
B cells
Functional
defect
Associated
features
OMIM
number
(e) SAMHD1
deficiency,
AGS5
Mutations in SAMHD1,
encoding negative
regulator of the
immunostimulatory DNA
response
AR Not assessed Not
assessed
Induction of the
cell intrinsic
antiviral response,
apoptosis, and
mitochondrial DNA
destruction leading
to increased CSF
alpha-IFN
production
Progressive encephalopathy
intracranial calcifications
612952
Cerebral atrophy,
leukodystrophy
HSMG, thrombocytopenia,
anemia elevated lactates
Chronic CSF lymphocytosis
Skin vasculitis, mouth ulcers,
arthropathy
(f) ADAR1
deficiency,
AGS6
Mutations in ADAR1,
encoding an RNA-specific
adenosine deaminase
AR Not assessed Not
assessed
Catalyzes the
deamination of
adenosine to
inosine in dsRNA
substrates
markedly elevated
CSF IFN-alpha
Progressive encephalopathy
intracranial calcification
Severe developmental delay,
leukodystrophy
615010
(g) Spondylo
enchondro-
dysplasia with
immune
dysregulation
(SPENCD)
Mutations in ACP5,
encoding tartrate-resistant
acid phosphatase (TRAP)
AR Not assessed Not
assessed
Upregulation of
IFN-alpha and type
I IFN-stimulated
genes
Recurrent bacterial and viral
infections, intracranial
calcification
607944
SLE-like autoimmunity
(Sjögren’s syndrome,
hypothyroidism,
inflammatory myositis,
Raynaud’s disease and
vitiligo), hemolytic anemia,
thrombocytopenia, skeletal
dysplasia, short stature
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; FHL, familial hemophagocytic lymphohistiocytosis; HLH, hemo-
phagocytic lymphohistiocytosis; HSMG, hepatosplenomegaly; DN, double negative; SLE, systemic lupus erythematous; IBD, inflammatory bowel disease; CSF,
chronic cerebrospinal fluid.
aTen or fewer unrelated cases reported in the literature.
bSomatic mutations of TNFRSF6 cause a similar phenotype (ALPS–sFAS), see Table 9. Germinal mutation and somatic mutation of TNFRSF6 can be associated in
some ALPS–FAS patients.
cAR ALPS–FAS patients have a most severe clinical phenotype.
dSomatic mutations in KRAS or NRAS can give this clinical phenotype associated autoimmune leukoproliferative disease (RALD) and are now included in Table 9
entitled phenocopies of PID.
eDe novo dominant TREX1 mutations have been reported.
Fourteen new disorders have been added to Table 4. Two new entries have been added in the table, including immune dysregulation with colitis and Type 1
interferonopathies. EBV-driven lymphoproliferation is also observed in MAGT1 deficiency (Table 1).
Table 5 | Congenital defects of phagocyte number, function, or both.
Disease Genetic defect/
presumed pathogenesis
Inheritance Affected
cells
Affected
function
Associated features OMIM
number
1. Defects of neutrophil function
(a) Severe congenital
neutropenia 1 (ELANE
deficiency)
Mutation in ELANE : misfolded
protein response, increased
apoptosis
AD N Myeloid
differentiation
Susceptibility to MDS/leukemia 202700
(b) SCN2a (GFI 1
deficiency)
Mutation in GFI1: loss of
repression of ELANE
AD N Myeloid
differentiation
B/T lymphopenia 613107
(Continued)
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Table 5 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Affected
cells
Affected
function
Associated features OMIM
number
(c) SCN3 (Kostmann
disease)
Mutation in HAX1: control of
apoptosis
AR N Myeloid
differentiation
Cognitive and neurological
defects in patients with defects
in both HAX1 isoforms,
susceptibility to MDS/leukemia
610738
(d) SCN4 (G6PC3
deficiency)
Mutation in G6PC3: abolished
enzymatic activity of glucose-
6-phosphatase, aberrant
glycosylation, and enhanced
apoptosis of N and F
AR N+F Myeloid
differentiation,
chemotaxis, O−2
production
Structural heart defects,
urogenital abnormalities, inner
ear deafness, and venous
angiectasias of trunks and limbs
612541
(e) SCN5 Mutation in VPS45 controls
vesicular trafficking
AR N+F Myeloid
differentiation,
migration
Extramedullary hematopoiesis,
bone marrow fibrosis,
nephromegaly
615285
(f) Glycogen storage
disease type 1b
Mutation in G6PT1:
glucose-6-phosphate
transporter 1
AR N+M Myeloid
differentiation,
chemotaxis, O−2
production
Fasting hypoglycemia, lactic
acidosis, hyperlipidemia,
hepatomegaly
232220
(g) Cyclic neutropenia Mutation in ELANE : misfolded
protein response
AD N Differentiation Oscillations of other leukocytes
and platelets
162800
(h) X-linked
neutropenia/a
myelodysplasia
Mutation in WAS: regulator of
actin cytoskeleton (loss of
auto-inhibition)
XL, gain-of-
function
N+M Mitosis Monocytopenia 300299
(i) P14/LAMTOR2
deficiency a
Mutation in
ROBLD3/LAMTOR2:
endosomal adaptor protein 14
AR N+L
Mel
Endosome
biogenesis
Neutropenia 610389
Hypogammaglobulinemia
↓ CD8 cytotoxicity
Partial albinism
Growth failure
(j) Barth syndrome Mutation in tafazzin (TAZ)
gene: abnormal lipid structure
of mitochondrial membrane,
defective carnitine metabolism
XL N Myeloid
differentiation
Cardiomyopathy, myopathy,
growth retardation
302060
(k) Cohen syndrome Mutation in COH1 gene: Pg
unknown
AR N Myeloid
differentiation
Retinopathy, developmental
delay, facial dysmorphisms
216550
(l) Clericuzio syndrome
poikiloderma with
neutropenia
Mutation in C16ORF57,
affects genomic integrity
AR N Myeloid
differentiation
Poikiloderma, neutropenia, MDS 613276
2. Defects of motility
(a) Leukocyte
adhesion deficiency
type 1 (LAD1)
Mutation in ITGB2: adhesion
protein (CD18)
AR N+M+
L+NK
Adherence,
chemotaxis,
endocytosis,
T/NK cytotoxicity
Delayed cord separation, skin
ulcers
Periodontitis
Leukocytosis
116920
(b) Leukocyte
adhesion deficiency
type 2 (LAD2)a
Mutation in FUCT1:
GDP-fucose transporter
AR N+M Rolling,
chemotaxis
Mild LAD type 1 features plus
hh-blood group plus mental and
growth retardation
266265
(c) Leukocyte
adhesion deficiency
type 3 (LAD3)
Mutation in KINDLIN3:
Rap1-activation of β1–3
integrins
AR N+M+
L+NK
Adherence,
chemotaxis
LAD type 1 plus bleeding
tendency
612840
(d) Rac 2 deficiencya Mutation in RAC2: regulation
of actin cytoskeleton
AD N Adherence,
chemotaxis, O−2
production
Poor wound healing,
leukocytosis
602049
(Continued)
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Disease Genetic defect/
presumed pathogenesis
Inheritance Affected
cells
Affected
function
Associated features OMIM
number
(e) β-Actin deficiencya Mutation in ACTB:
cytoplasmic actin
AD N+M Motility Mental retardation, short
stature
102630
(f) Localized juvenile
periodontitis
Mutation in FPR1: chemokine
receptor
AR N Formylpeptide
induced
chemotaxis
Periodontitis only 136537
(g) Papillon–Lefèvre
syndrome
Mutation in CTSC : cathepsin
C activation of serine
proteases
AR N+M Chemotaxis Periodontitis, palmoplantar
hyperkeratosis in some patients
245000
(h) Specific granule
deficiencya
Mutation in C/EBPE : myeloid
transcription factor
AR N Chemotaxis Neutrophils with bilobed nuclei;
absent secondary granules and
defensins
245480
(i) Shwachman–
Diamond syndrome
Mutation in SBDS: defective
ribosome synthesis
AR N Chemotaxis Pancytopenia, exocrine
pancreatic insufficiency,
chondrodysplasia
260400
3. Defects of respiratory burst
(a) X-linked chronic
granulomatous
disease (CGD)
Mutation in CYBB: electron
transport protein (gp91phox)
XL N+M Killing (faulty O−2
production)
Recurrent bacterial infection,
susceptibility to fungal infection,
inflammatory gut
manifestations McLeod
phenotype in patients with
deletions extending into the
contiguous Kell locus
306400
(b) Autosomal
recessive CGD – p22
phox deficiency
Mutation in CYBA: electron
transport protein (p22phox)
AR N+M Killing (faulty O−2
production)
Recurrent bacterial infection,
susceptibility to fungal infection,
and inflammatory gut
manifestations
233690
(c) Autosomal
recessive CGD – p47
phox deficiency
Mutation in NCF1: adapter
protein (p47phox)
AR N+M Killing (faulty O−2
production)
Recurrent bacterial infection,
susceptibility to fungal infection,
and inflammatory gut
manifestations
233700
(d) Autosomal
recessive CGD – p67
phox deficiency
Mutation in NCF2: activating
protein (p67phox)
AR N+M Killing (faulty O−2
production)
Recurrent bacterial infection,
susceptibility to fungal infection,
inflammatory gut
manifestations
233710
(e) Autosomal
recessive CGD – p40
phox deficiencya
Mutation in NCF4: activating
protein (p40phox)
AR N+M Killing (faulty O−2
production)
Inflammatory gut
manifestations only
601488
4. Mendelian susceptibility to mycobacterial disease (MSMD)
(a) IL-12 and IL-23
receptor β1 chain
deficiency
Mutation in IL-12RB1: IL-12 and
IL-23 receptor β1 chain
AR L+NK IFN-γ secretion Susceptibility to Mycobacteria
and Salmonella
209950
(b) IL-12p40 deficiency Mutation in IL-12B: subunit
p40 of IL-12/IL-23
AR M IFN-γ secretion Susceptibility to Mycobacteria
and Salmonella
161561
(c) IFN-γ receptor 1
deficiency
Mutation in IFNGR1: IFN-γR
ligand binding chain
AR, AD M+L IFN-γ binding
and signaling
Susceptibility to Mycobacteria
and Salmonella
107470
(d) IFN-γ receptor 2
deficiency
Mutation in IFNGR2: IFN-γR
accessory chain
AR M+L IFN-γ signaling Susceptibility to Mycobacteria
and Salmonella
147569
(e) STAT1 deficiency
(AD form)a
Mutation in STAT1 (loss of
function)
AD M+L IFN-γ signaling Susceptibility to Mycobacteria 600555
(Continued)
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Disease Genetic defect/
presumed pathogenesis
Inheritance Affected
cells
Affected
function
Associated features OMIM
number
(f) Macrophage gp91
phox deficiencya
Mutation in CYBB: electron
transport protein (gp 91 phox)
XL Mf only Killing (faulty O−2
production)
Isolated susceptibility to
Mycobacteria
306400
(g) IRF8-deficiency
(AD form)a
Mutation in IRF8 : IL-12
production by CD1c+ MDC
AD CD1c+
MDC
Differentiation of
CD1c+MDC
subgroup
Susceptibility to Mycobacteria 601565
(h) ISG15 Mutation in ISG15 ; an
interferon (IFN) α/β-inducible,
ubiquitin-like intracellular
protein
AR M+N+L IFN-γ secretion Susceptibility to Mycobacteria 14751
5. Other defects
(a) IRF 8-deficiency
(AR form)a
Mutation in IRF8 : IL-12
production
AR Monocytes
periph-
eral
DC
Cytopenias Susceptibility to Mycobacteria,
Candida, myeloproliferation
614893
(b) GATA2 deficiency
(Mono MAC
syndrome)
Mutation in GATA2: loss of
stem cells
AD Monocytes
periph-
eral
DC+NK+B
Multilineage
cytopenias
Susceptibility to Mycobacteria,
papilloma viruses,
histoplasmosis, alveolar
proteinosis, MDS/AML/CMML
137295
(c) Pulmonary alveolar
proteinosisa
Mutation in CSF2RA Biallelic
mutations in
pseudo-
autosomal
gene
Alveolar
macro-
phages
GM-CSF
signaling
Alveolar proteinosis 306250
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; ACTB, actin beta; B, B lymphocytes; CEBPE, CCAAT/enhancer-
binding protein epsilon; CMML, chronic myelomonocytic leukemia; CTSC, cathepsin C; CYBA, cytochrome b alpha subunit; CYBB, cytochrome b beta subunit;
DC, dendritic cells; ELANE, elastase neutrophil-expressed; GATA2, GATA binding protein 2; IFN, interferon; IFNGR1, interferon-gamma receptor subunit 1; IFNGR2,
interferon-gamma receptor subunit 2; IL-12B, interleukin-12 beta subunit; IL-12RB1, interleukin-12 receptor beta 1; IFR8, interferon regulatory factor 8; F, fibroblasts;
FPR1, formylpeptide receptor 1; FUCT1, fucose transporter 1; GFI1, growth factor independent 1; HAX1, HLCS1-associated protein X1; ITGB2, integrin beta-2; L,
lymphocytes; M, monocytes–macrophages; MDC, myeloid dendritic cells; MDS, myelodysplasia; Mel, melanocytes; Mφ, macrophages; MSMD, Mendelian suscepti-
bility to mycobacterial disease; N, neutrophils; NCF1, neutrophil cytosolic factor 1; NCF2, neutrophil cytosolic factor 2; NCF4, neutrophil cytosolic factor 4; NK, natural
killer cells; ROBLD3: roadblock domain containing 3; SBDS, Shwachman–Bodian–Diamond syndrome; STAT, signal transducer and activator of transcription.
aTen or fewer unrelated cases reported in the literature.
Table 5 includes seven newly described genetic defects of phagocyte number and/or function including Barth syndrome, Cohen syndrome, and poikiloderma with
neutropenia. In these three clinically well-known diseases, the genetic defects have been elucidated, although their molecular pathogenesis remains ill-defined. A
new cause of autosomal recessive chronic granulomatous disease, namely a deficiency of the cytosolic activating protein p40 phox, has now been found in two
CGD patients and is included under defects of respiratory burst. Under the heading of Mendelian susceptibility of mycobacterial disease (MSMD), two new entities
were added: (a) a subgroup of X-linked gp91 phox deficiency with isolated susceptibility to mycobacteria and a defect of the respiratory burst in macrophages only;
(b) an autosomal dominant form of IRF8-deficiency, resulting from a lack of CD1c+ myeloid dendritic cells that would normally secrete IL-12. The clinical phenotype
of MSMD may vary, depending on the nature of the genetic defect. Finally, GATA2 deficiency was recently identified as the cause of the Mono MAC syndrome,
with multilineage cytopenias (of monocytes, peripheral dendritic cells, NK- and B-lymphocytes) resulting in opportunistic infections (including mycobacteria), alveolar
proteinosis, and malignancy.
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Table 6 | Defects in innate immunity.
Disease Genetic defect/
presumed pathogenesis
Inheritance Affected cell Functional
defect
Associated features OMIM
number
1. Anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID)
(a) EDA-ID, X-linked
(NEMO deficiency)
Mutations of NEMO
(IKBKG), a modulator of
NF-κB activation
XL Lymphocytes+
monocytes
NF-κB signaling
pathway
Various infections (bacteria,
Mycobacteria, viruses, and
fungi)
300248
Colitis
EDA (not in all patients)
Hypogammaglobulinemia to
specific antibody
polysaccharides deficiency
(b) EDA-ID,
autosomal-
dominanta
Gain-of-function
mutations of IKBA,
resulting in impaired
activation of NF-κB
AD Lymphocytes+
monocytes
NF-κB signaling
pathway
Various infections (bacteria,
viruses, and fungi)
612132
EDA
T cell defect
2. TIR signaling pathway deficiency
(a) IRAK-4 deficiency Mutations of IRAK-4, a
component of TLR- and
IL-1R-signaling pathway
AR Lymphocytes+
granulocytes+
monocytes
TIR–IRAK signaling
pathway
Bacterial infections
(pyogenes)
607676
(b) MyD88
deficiency
Mutations of MYD88, a
component of the TLR
and IL-1R signaling
pathway
AR Lymphocytes+
granulocytes+
monocytes
TIR–MyD88 signaling
pathway
Bacterial infections
(pyogenes)
612260
3. HOIL1 deficiencya Mutation of HOIL1, a
component of LUBAC
AR Lymphocytes+
granulocytes+
monocytes
NF-κB signaling
pathway
Bacterial infections
(pyogenes)
Not
assigned
Autoinflammation
Amylopectinosis
4. WHIM (Warts,
hypogammaglobu-
linemia, infections,
myelokathexis)
syndrome
Gain-of-function
mutations of CXCR4, the
receptor for CXCL12
AD Granulocytes+
lymphocytes
Increased response
of the CXCR4
chemokine receptor
to its ligand CXCL12
(SDF-1)
Warts/human papilloma virus
(HPV) infection
193670
Neutropenia
Reduced B cell number
Hypogammaglobulinemia
5. Epidermodysplasia verruciformis
EVER1 deficiency Mutations of EVER1 AR Keratinocytes
and leukocytes
EVER proteins may
be involved in the
regulation of cellular
zinc homeostasis in
lymphocytes
HPV (group B1) infections and
cancer of the skin (typical EV)
226400
EVER2 deficiency Mutations of EVER2 AR Keratinocytes
and leukocytes
EVER proteins may
be involved in the
regulation of cellular
zinc homeostasis in
lymphocytes
HPV (group B1) infections and
cancer of the skin (typical EV)
226400
6. Predisposition to severe viral infection
(a) STAT2 deficiencya Mutations of STAT2 AR T and NK cells STAT2-dependent Severe viral infections
(disseminated vaccine-strain
measles)
Not
assignedIFN-α and -β
response
(Continued)
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Disease Genetic defect/
presumed pathogenesis
Inheritance Affected cell Functional
defect
Associated features OMIM
number
(b) MCM4
deficiencya
Mutations in MCM4 AR NK cells DNA repair disorder Viral infections (EBV, HSV,
VZV)
609981
Adrenal failure
Short stature
7. Herpes simplex encephalitis (HSE)
(a) TLR3 deficiencya (b) Mutations of TLR3 AD Central
nervous
system (CNS)
resident cells
and fibroblasts
TLR3-dependent Herpes simplex virus 1
encephalitis (incomplete
clinical penetrance for all
etiologies listed here)
613002
AR IFN-α, -β, and -λ
induction
(b) UNC93B1
deficiencya
(a) Mutations of
UNC93B1
AR CNS resident
cells and
fibroblasts
UNC-93B-dependent Herpes simplex virus 1
encephalitis
610551
IFN-α, -β, and -λ
induction
(c) TRAF3
deficiencya
(c) Mutations of TRAF3 AD CNS resident
cells and
fibroblasts
TRAF3-dependent Herpes simplex virus 1
encephalitis
614849
IFN-α, -β, and -λ
induction
(d) TRIF deficiencya (c) Mutations of TRIF AD CNS resident
cells and
fibroblasts
TRIF-dependent Herpes simplex virus 1
encephalitis
614850
AR IFN-α, -β, and -λ
induction
(e) TBK1 deficiencya (c) Mutations of TBK1 AD CNS resident
cells and
fibroblasts
TBK1-dependent Herpes simplex virus 1
encephalitis
Not
assignedIFN-α, -β, and -λ
induction
8. Predisposition to invasive fungal diseasesa
CARD9 deficiency Mutations of CARD9 AR Mononuclear
phagocytes
CARD9 signaling
pathway
Invasive candidiasis infection
Deep dermatophytoses
212050
9. Chronic mucocutaneous candidiasis (CMC)
(a) IL-17RA
deficiencya
(a) Mutations in IL-17RA AR Epithelial cells,
fibroblasts,
mononuclear
phagocytes
IL-17RA signaling
pathway
CMC
Folliculitis
605461
(b) IL-17F deficiencya (b) Mutations in IL-17F AD T cells IL-17F-containing
dimers
CMC
Folliculitis
606496
(c) STAT1
gain-of-function
(c) Gain-of-function
mutations in STAT1
AD T cells Gain-of-function
STAT1 mutations that
impair the
development of
IL-17-producing T cells
CMC 614162
Various fungal, bacterial, and
viral (HSV) infections
Autoimmunity (thyroiditis,
diabetes, cytopenia)
Enteropathy
(d) ACT1 deficiencya (c) Mutations in ACT1 AR T cells,
fibroblasts
Fibroblasts fail to
respond to IL-17A and
IL-17F, and their T
cells to IL-17E
CMC 615527
Blepharitis, folliculitis, and
macroglossia
10. Trypanosomiasisa Mutations in APOL-I AD APOL-I Trypanosomiasis 603743
(Continued)
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Disease Genetic defect/
presumed pathogenesis
Inheritance Affected cell Functional
defect
Associated features OMIM
number
11. Isolated
congenital asplenia
(ICA)
Mutations in RPSA AD Spleen RPSA encodes
ribosomal protein SA,
a component of the
small subunit of the
ribosome
Bacteremia (encapsulated
bacteria)
No spleen
271400
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; NF-κB, nuclear factor kappa B;TIR,Toll and interleukin 1 receptor;
IFN, interferon; HVP, human papilloma virus; TLR, Toll-like receptor; IL, interleukin.
aTen or fewer unrelated cases reported in the literature.
Eight new disorders have been added to Table 6. Three new entries have been added in the table. One is a new PID with the association of recurrent bacterial
infections, autoinflammation, and amylopectinosis caused by AR HOIL1 mutations found in two kindreds.The second is severe viral infection, for which three genetic
etiologies have been discovered. AR-STAT2 deficiency and AR-CD16 deficiency have been found in one kindred each. AR MCM4 deficiency has been found in several
Irish kindreds. The third is isolated congenital asplenia identified in 18 patients from 8 kindreds.
XR-EDA-ID is highly heterogeneous clinically, both in terms of developmental features (some patients display osteopetrosis and lymphedema, in addition to EDA,
while others do not display any developmental features) and infectious diseases (some display multiple infections, viral, fungal, and bacterial, while others display a
single type of infection). The various OMIM entries correspond to these distinct clinical diseases.
Table 7 | Autoinflammatory disorders.
Disease Genetic defect/
presumed pathogenesis
Inheritance Affected
cells
Functional
defects
Associated
features
OMIM
number
1. Defects effecting the inflammasome
(a) Familial
Mediterranean fever
Mutations of MEFV (lead
to gain of pyrin function,
resulting in inappropriate
IL-1β release)
AR Mature
granulocytes,
cytokine-activated
monocytes
Decreased production
of pyrin permits
ASC-induced IL-1
processing and
inflammation following
subclinical serosal
injury; macrophage
apoptosis decreased
Recurrent fever,
serositis, and
inflammation
responsive to
colchicine. Predisposes
to vasculitis and
inflammatory bowel
disease
249100
(b) Mevalonate kinase
deficiency (hyper IgD
syndrome)
Mutations of MVK (lead to
a block in the mevalonate
pathway). Interleukin-1beta
mediates the inflammatory
phenotype
AR Affecting cholesterol
synthesis;
pathogenesis of
disease is unclear
Periodic fever and
leukocytosis with high
IgD levels
260920
(c) Muckle–Wells
syndrome
Mutations of CIAS1 (also
called PYPAF1 or NALP3)
lead to constitutive
activation of the NLRP3
inflammasome
AD PMNs monocytes Defect in cryopyrin,
involved in leukocyte
apoptosis and NF-κB
signaling and IL-1
processing
Urticaria, SNHL,
amyloidosis
191900
(d) Familial cold
autoinflammatory
syndrome
Mutations of CIAS1 (see
above)
Mutations of NLRP12
AD PMNs,
monocytes
Same as above Non-pruritic urticaria,
arthritis, chills, fever,
and leukocytosis after
cold exposure
120100
(Continued)
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Disease Genetic defect/
presumed pathogenesis
Inheritance Affected
cells
Functional
defects
Associated
features
OMIM
number
5. Neonatal onset
multisystem
inflammatory disease
(NOMID) or chronic
infantile neurologic
cutaneous and articular
syndrome (CINCA)
Mutations of CIAS1 (see
above)
AD PMNs,
chondrocytes
Same as above Neonatal onset rash,
chronic meningitis, and
arthropathy with fever
and inflammation
607115
2. Non inflammasome-related conditions
(a) TNF
receptor-associated
periodic syndrome
(TRAPS)
Mutations of TNFRSF1
(resulting in increased TNF
inflammatory signaling)
AD PMNs,
monocytes
Mutations of 55-kDa
TNF receptor leading to
intracellular receptor
retention or diminished
soluble cytokine
receptor available to
bind TNF
Recurrent fever,
serositis, rash, and
ocular or joint
inflammation
142680
(b) Early-onset
inflammatory bowel
disease
Mutations in IL-10 (results
in increase many
proinflammatory
cytokines)
AR Monocyte/
macrophage,
activated T cells
IL-10 deficiency leads to
increase of TNFγ and
other proinflammatory
cytokines
Early-onset enterocolitis
enteric fistulas, perianal
abscesses, chronic
folliculitis
124092
(b) Early-onset
inflammatory bowel
disease
Mutations in IL-10RA (see
above)
AR Monocyte/
macrophage,
activated T cells
Mutation in IL-10
receptor alpha leads to
increase of TNFγ and
other proinflammatory
cytokines
Early-onset enterocolitis
enteric fistulas, perianal
abscesses, chronic
folliculitis
146933
(b) Early-onset
inflammatory bowel
disease
Mutations in IL-10RB (see
above)
AR Monocyte/
macrophage,
activated T cells
Mutation in IL-10
receptor beta leads to
increase of TNFγ and
other proinflammatory
cytokines
Early-onset enterocolitis
enteric fistulas, perianal
abscesses, chronic
folliculitis
123889
(c) Pyogenic sterile
arthritis, pyoderma
gangrenosum, acne
(PAPA) syndrome
Mutations of PSTPIP1 (also
called C2BP1) (affects both
pyrin and protein tyrosine
phosphatase to regulate
innate and adaptive
immune responses)
AD Hematopoietic
tissues,
upregulated in
activated T cells
Disordered actin
reorganization leading
to compromised
physiologic signaling
during inflammatory
response
Destructive arthritis,
inflammatory skin rash,
myositis
604416
(d) Blau syndrome Mutations of NOD2 (also
called CARD15) (involved
in various inflammatory
processes)
AD Monocytes Mutations in nucleotide
binding site of CARD15,
possibly disrupting
interactions with
lipopolysaccharides and
NF-κB signaling
Uveitis, granulomatous
synovitis,
camptodactyly, rash,
and cranial
neuropathies, 30%
develop Crohn’s disease
186580
10. Chronic recurrent
multifocal osteomyelitis
and congenital
dyserythropoietic
anemia (Majeed
syndrome)a
Mutations of LPIN2
(increased expression of
the proinflammatory
genes)
AR Neutrophils, bone
marrow cells
Undefined Chronic recurrent
multifocal
osteomyelitis,
transfusion-dependent
anemia, cutaneous
inflammatory disorders
609628
(Continued)
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Table 7 | Continued
Disease Genetic defect/
presumed pathogenesis
Inheritance Affected
cells
Functional
defects
Associated
features
OMIM
number
11. DIRA (deficiency of
the interleukin 1
receptor antagonist)a
Mutations of IL-1RN (see
functional defect)
AR PMNs,
monocytes
Mutations in the IL-1
receptor antagonist
allow unopposed action
of Interleukin 1
Neonatal onset of
sterile multifocal
osteomyelitis,
periostitis, and
pustulosis
612852
12. DITRA – deficiency
of IL-36 receptor
antagonist
Mutation in IL-36RN (see
functional defect)
AR Keratinocyte
leukocytes
Mutations in IL-36RN
leads to increase IL-8
production
Pustular psoriasis 614204
13. SLC29A3 mutation Mutation in SLC29A3 (?) AR Leukocyte, bone
cells
Macrophage activation? Hyperpigmentation
hypertrichosis
602782
14. CAMPS (CARD14
mediated psoriasis)
Mutation in CARD14 (see
functional defect)
AD Mainly in
keratinocyte
Mutations in CARD14
activate the NF-κB
pathway and production
of IL-8
Psoriasis 173200
15. Cherubism Mutation in SH3BP2 (see
functional defect)
AD Stroma cells,
bone cells
Hyperactivated
macrophage and
increased NF-κB
Bone degeneration in
jaws
11840
16. CANDLE (chronic
atypical neutrophilic
dermatitis with
lipodystrophy)
Mutation in PSMB8 (see
functional defect)
AD Keratinocyte, B
cell adipose cells
Mutations cause
increase IL-6 production
Dystrophy, panniculitis 256040
17. HOIL1 deficiency Mutation in HOIL1 (see
functional defect)
AR PMNs, fibroblast Mutation in HOIL1
leads to IL-1β
dysfunction
Immunodeficiency
autoinflammation
amylopectinosis
610924
18. PLAID (PLCγ2
associated antibody
deficiency and immune
dysregulation)
Mutation in PLCG2 (see
functional defect)
AD B cells, NK, mast
cells
Mutations cause
activation of IL-1
pathways
Cold urticaria hypogam-
maglobulinemia
614878
AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; PMN, polymorphonuclear cells; ASC, apoptosis-associated speck-like protein with a cas-
pase recruitment domain; CARD, caspase recruitment domain; CD2BP1, CD2 binding protein 1; PSTPIP1, proline/serine/threonine phosphatase-interacting protein
1; SNHL, sensorineural hearing loss; CIAS1, cold-induced autoinflammatory syndrome 1.
aTen or fewer unrelated cases reported in the literature.
Autoinflammatory diseases are clinical disorders marked by abnormally increased inflammation, mediated predominantly by the cells and molecules of the innate
immune system, with a significant host predisposition. While the genetic defect of one of the most common autoinflammatory conditions, PFAPA, is not known,
recent studies suggest that it is associated with activation of IL-1 pathway and response to IL-1beta antagonists.
Muckle–Wells syndrome, familial cold autoinflammatory syndrome and neonatal onset multisystem inflammatory disease (NOMID), which is also called chronic
infantile neurologic cutaneous and articular syndrome (CINCA) are caused by similar mutations in CIAS1 mutations. The disease phenotype in any individual appears
to depend on modifying effects of other genes and environmental factors.
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Table 8 | Complement deficiencies.
Disease Genetic defect;
presumed pathogenesis
Inheritance Functional defect Associated features OMIM
number
1. C1q deficiency Mutation in C1QA, C1QB,
C1QC : classical complement
pathway components
AR Absent CH50 hemolytic activity,
defective activation of the
classical pathway
SLE, infections with
encapsulated organisms
120550;
601269;
120575
Diminished clearance of
apoptotic cells
2. C1r deficiency Mutation in C1R: classical
complement pathway
component
AR Absent CH50 hemolytic activity,
defective activation of the
classical pathway
SLE, infections with
encapsulated organisms
216950
3. C1s deficiency Mutation in C1S: classical
complement pathway
component
AR Absent CH50 hemolytic activity,
defective activation of the
classical pathway
SLE, infections with
encapsulated organisms
120580
4. C4 deficiency Mutation in C4A, C4B: classical
complement pathway
components
AR Absent CH50 hemolytic activity,
defective activation of the
classical pathway, defective
humoral immune response to
carbohydrate antigens in some
patients
SLE, infections with
encapsulated organisms
120810;
120820
5. C2 deficiency Mutation in C2: classical
complement pathway
component
AR Absent CH50 hemolytic activity,
defective activation of the
classical pathway
SLE, infections with
encapsulated organisms,
atherosclerosis
217000
6. C3 deficiency Mutation in C3: central
complement component
AR, gain-of-
function AD
Absent CH50 and AH50
hemolytic activity defective
opsonization
Infections;
glomerulonephritis
120700
Defective humoral immune
response
Atypical hemolytic–uremic
syndrome with
gain-of-function mutations
7. C5 deficiency Mutation in C5 : terminal
complement component
AR Absent CH50 and AH50
hemolytic activity; defective
bactericidal activity
Neisserial infections 120900
8. C6 deficiency Mutation in C6 : terminal
complement component
AR Absent CH50 and AH50
hemolytic activity; defective
bactericidal activity
Neisserial infections 217050
9. C7 deficiency Mutation in C7 : terminal
complement component
AR Absent CH50 and AH50
hemolytic activity; defective
bactericidal activity
Neisserial infections 217070
10. C8 α–γ deficiency Mutation in C8A, C8G: terminal
complement components
AR Absent CH50 and AH50
hemolytic activity; defective
bactericidal activity
Neisserial infections 120950
11. C8b deficiency Mutation in C8B: Terminal
complement component
AR Absent CH50 and AH50
hemolytic activity; defective
bactericidal activity
Neisserial infections 120960
12. C9 deficiency Mutation in C9: Terminal
complement component
AR Reduced CH50 and AP50
hemolytic activity; deficient
bactericidal activity
Mild susceptibility to
Neisserial infections
613825
(Continued)
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Table 8 | Continued
Disease Genetic defect;
presumed pathogenesis
Inheritance Functional defect Associated features OMIM
number
13. C1 inhibitor
deficiency
Mutation in SERPING1:
regulation of kinins and
complement activation
AD Spontaneous activation of the
complement pathway with
consumption of C4/C2
Hereditary angioedema 138470
Spontaneous activation of the
contact system with generation
of bradykinin from high
molecular weight kininogen
14. Factor Ba Mutation in CFB: activation of
the alternative pathway
AD Gain-of-function mutation with
increased spontaneous AH50
aHUS 138470
15. Factor D
deficiency
Mutation in CFD: regulation of
the alternative complement
pathway
AR Absent AH50 hemolytic activity Neisserial infections 134350
16. Properdin
deficiency
Mutation in CFP : regulation of
the alternative complement
pathway
XL Absent AH50 hemolytic activity Neisserial infections 312060
17. Factor I deficiency Mutation in CFI: regulation of the
alternative complement pathway
AR Spontaneous activation of the
alternative complement pathway
with consumption of C3
Infections, Neisserial
infections, aHUS,
preeclampsia,
membranoproliferative
glomerulonephritis
(MPGN)
610984
18. Factor H
deficiency
Mutation in CFH : regulation of
the alternative complement
pathway
AR Spontaneous activation of the
alternative complement pathway
with consumption of C3
Infections, Neisserial
infections, aHUS,
preeclampsia,
membranoproliferative
glomerulonephritis
(MPGN)
609814
19. Factor H-related
protein deficiencies
Mutation in CFHR1-5 : bind C3b AR Normal CH50, AH50,
autoantibodies to Factor H
aHUS 235400
20. Thrombomodulina Mutation in THBD: regulates
complement and coagulant
activation
AD Normal CH50, AH50 aHUS 188040
21. MASP1 deficiency Mutation in MASP1: cleaves C2
and activates MASP2
AR Deficient activation of the lectin
activation pathway, cell migration
Infections, 3MC syndrome 600521
22. MASP2
deficiencya
MASP2: cleavage of C2 and C4 AR Deficient activation of the lectin
activation pathway
Pyogenic infections;
inflammatory lung disease,
autoimmunity
605102
23. 3MC syndrome
COLEC11 deficiencya
Mutation in COLEC11: binds
MASP1, MASP3
AR Loss of neural crest cell
migration signals
A developmental
syndrome of facial
dysmorphism, cleft lip
and/or palate,
craniosynostosis, learning
disability, and genital, limb,
and vesicorenal anomalies
(3MC syndrome)
612502
(Continued)
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Table 8 | Continued
Disease Genetic defect;
presumed pathogenesis
Inheritance Functional defect Associated features OMIM
number
24. Complement
receptor 2 (CR2)
deficiencya
Mutation in CD21 AR See CD21 deficiency inTable 3 120650
25. Complement
receptor 3 (CR3)
deficiency
Mutation in ITGB2 AR See LAD1 inTable 5 116920
Membrane cofactor
protein (CD46)
deficiency
Mutation in CD46 : dissociates
C3b and C4b
AD Inhibitor of complement
alternate pathway, decreased
C3b binding
aHUS, infections,
preeclampsia
120920
Membrane Attack
Complex inhibitor
(CD59) deficiencya
Mutation in CD59: regulates the
membrane attack complex
formation
AR Erythrocytes highly susceptible
to complement-mediated lysis
Hemolytic anemia,
polyneuropathy
107271
Ficolin 3 deficiencya Mutation in FCN3: activates the
classical complement pathway
AR Absence of complement
activation by the Ficolin 3
pathway
Respiratory infections,
abscesses
604973
XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; MAC, membrane attack complex; SLE, systemic lupus
erythematosus; MBP, mannose-binding protein; MASP2, MBP-associated serine protease 2.
aTen or fewer unrelated cases reported in the literature.
New entities added toTable 8 demonstrate the important role of complement regulators in a group of well-described inflammatory disorders. In particular, we have
added mutations in membrane bound as well as surface attached soluble complement regulatory proteins recognized in hemolytic–uremic syndrome, age-related
macular degeneration, and preeclampsia. The connecting theme of these otherwise unrelated clinical events is excessive activation or insufficient regulation of C3;
these events lead to recruitment of leukocytes and permit secretion of inflammatory and anti-angiogenic mediators that disrupt the vascular bed of the target organ.
Alterations in the genes for Factor B (CFB), Factor I (CFI), Factor H (CFH), and CD46 act as susceptibility genes rather than disease causing mutations. Population
studies reveal no detectable increase in infections in MBP (also known at mannose-binding lectin – MBL) deficient adults. The 3MC syndrome, a developmental
syndrome, has been variously called Carnevale, Mingarelli, Malpuech, and Michels syndrome.
Table 9 | Phenocopies of PID.
Disease Genetic defect/
presumed pathogenesis
CirculatingT cells Circulating B cells Serum Ig Associated features/
similar PID
Associated with
somatic mutations
(a) Autoimmune
lymphoproliferative
syndrome (ALPS–SFAS)
Somatic mutation in
TNFRSF6
Increased CD4− CD8−
double negative (DN) T
alpha/beta cells
Normal, but increased
number of CD5+ B cells
Normal or
increased
Splenomegaly,
lymphadenopathy,
autoimmune cytopenias
Defective lymphocyte
apoptosis/ALPS–FAS
(=ALPS type Im)
(b) RAS-associated
autoimmune
leukoproliferative
disease (RALD)
Somatic mutation in KRAS
(gain-of-function)
Normal B cell lymphocytosis Normal or
increased
Splenomegaly,
lymphadenopathy,
autoimmune cytopenias,
granulocytosis,
monocytosis/ALPS-like
(Continued)
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Table 9 | Continued
Disease Genetic defect/
presumed pathogenesis
CirculatingT cells Circulating B cells Serum Ig Associated features/
similar PID
(c) RAS-associated
autoimmune
leukoproliferative
disease (RALD)
Somatic mutation in NRAS
(gain-of-function)
Increased CD4− CD8−
double negative (DN) T
alpha/beta cells
Lymphocytosis Splenomegaly,
lymphadenopathy,
autoantibodies/ALPS-like
Associated with
autoantibodies
(a) Chronic
mucocutaneous
candidiasis (isolated or
with APECED
syndrome)
Germline mutation in AIRE
AutoAb to IL-17 and/or IL-22
Normal Normal Normal Endocrinopathy, chronic
mucocutaneous
candidiasis/CMC
(b) Adult-onset
immunodeficiency
AutoAb to IFN gamma Decreased naive T cells Normal Normal Mycobacterial, fungal,
Salmonella VZV
infections/MSMD, or CID
(c) Recurrent skin
infection
AutoAb to IL-6 Normal Normal Normal Staphylococcal
infections/STAT3
deficiency
(d) Pulmonary alveolar
proteinosis
AutoAb to GM-CSF Normal Normal Normal Pulmonary alveolar
proteinosis, cryptococcal
meningitis/CSF2RA
deficiency
(e) Acquired
angioedema
AutoAb to CI inhibitor Normal Normal Normal Angioedema/C1 INH
deficiency (hereditary
angioedema)
The rapid advances in gene identification technology, including
the widespread use of whole exome and whole genome sequenc-
ing, has meant that the ability to identify gene defects in affected
families and even single individuals with inherited diseases has
grown enormously. In this report, over 30 new gene defects have
been added that were identified since the previous classification in
November, 2011. These defects can be found in all major groups
of PIDs included in this report. In many cases, the mutations are
not necessarily in genes formally implicated in immune cell func-
tion but are genes involved in essential cell processes. The more
detailed analysis and functional consequences of such defects as
illustrated by these PIDs will increase our understanding of the
interplay between different cellular processes in the development
and function of the immune system.
Among the newly identified, gene defects are many that are to
date particular to a single pedigree or individual; such defects may
prove exceedingly rare, or indeed may not necessarily be found
to recur in other individuals. We have marked conditions for
which there are 10 or fewer reported individuals with an aster-
isk, although historically, following the description of the first
few cases, additional individuals with a similar PID phenotype
and genotype have often been recognized. It is likely that we will
uncover many more “personal” or very rare gene defects over time
and that the spectrum of PIDs will become increasingly diverse and
complex, due to contributions of both environmental exposures
and genetic modifiers to each affected individual. The value of this
report therefore to capture and catalog the full spectrum at any
one time point becomes increasingly important.
The goal of the IUIS Expert Committee on PIDs is to increase
awareness, facilitate recognition, and promote optimal treatment
for patients with PIDs. In addition to the current report and pre-
vious “classification table” publications, the committee has also
produced a “Phenotypic Approach for IUIS PID Classification
and Diagnosis: Guidelines for Clinicians at the Bedside,” which
aims to lead physicians to particular groups of PIDs starting from
clinical features and combining routine immunological investiga-
tions. Together, these contributions will hopefully allow a practical
clinical framework for PID diagnosis. The committee also aims to
establish a classification of PIDs based on other aspects and will
work on publishing further guidelines in due course.
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